Ausgabe Sonderheft 3/2011
Natalizumab International Exchange Meeting
Inhalt (6 Artikel)
Swedish natalizumab (Tysabri) multiple sclerosis surveillance study
Fredrik Piehl, C. Holmén, J. Hillert, T. Olsson
Efficacy and tolerability of natalizumab in relapsing–remitting multiple sclerosis patients: a post-marketing observational study
F. Sangalli, L. Moiola, S. Bucello, P. Annovazzi, A. Rizzo, M. Radaelli, G. Vitello, L. M. E. Grimaldi, A. Ghezzi, V. Martinelli, G. Comi
Natalizumab treatment in multiple sclerosis: the experience of S. Andrea MS Centre in Rome
L. Prosperini, G. Borriello, F. Fubelli, F. Marinelli, Carlo Pozzilli
The cohort of the multiple sclerosis center of Cagliari
M. G. Marrosu, L. Lorefice, J. Frau, G. Coghe, G. Fenu, R. Piras, M. Melis, E. Cocco
Natalizumab efficacy on cognitive impairment in MS
F. Mattioli, C. Stampatori, F. Bellomi, R. Capra
Improvement of visual acuity in patients with severe visual loss affected by multiple sclerosis treated with natalizumab: a case report
Ciro Florio, Giorgia Teresa Maniscalco